A detailed history of Northern Trust Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,390,448 shares of ILMN stock, worth $145 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,390,448
Previous 1,434,989 3.1%
Holding current value
$145 Million
Previous $200 Million 4.44%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $5.69 Million - $6.56 Million
-44,541 Reduced 3.1%
1,390,448 $191 Million
Q4 2023

Feb 13, 2024

SELL
$92.79 - $142.53 $23.7 Million - $36.5 Million
-255,737 Reduced 15.13%
1,434,989 $200 Million
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $2.44 Million - $3.65 Million
-18,964 Reduced 1.11%
1,690,726 $232 Million
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $13.3 Million - $16.9 Million
-72,453 Reduced 4.07%
1,709,690 $321 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $212,350 - $254,874
-1,096 Reduced 0.06%
1,782,143 $414 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $24.3 Million - $31.5 Million
129,691 Added 7.84%
1,783,239 $361 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $811,358 - $1.04 Million
4,578 Added 0.28%
1,653,548 $315 Million
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $5.58 Million - $11.3 Million
-30,750 Reduced 1.83%
1,648,970 $304 Million
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $2.12 Million - $2.96 Million
-6,979 Reduced 0.41%
1,679,720 $587 Million
Q4 2021

Feb 08, 2022

BUY
$347.28 - $421.83 $12.1 Million - $14.7 Million
34,963 Added 2.12%
1,686,699 $642 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $4.03 Million - $5.21 Million
9,924 Added 0.6%
1,651,736 $670 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $2.84 Million - $3.67 Million
-7,627 Reduced 0.46%
1,641,812 $777 Million
Q1 2021

May 12, 2021

SELL
$361.28 - $504.76 $6.13 Million - $8.57 Million
-16,980 Reduced 1.02%
1,649,439 $633 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $24.2 Million - $30.6 Million
82,617 Added 5.22%
1,666,419 $617 Million
Q3 2020

Nov 16, 2020

SELL
$268.51 - $400.74 $8.17 Million - $12.2 Million
-30,422 Reduced 1.88%
1,583,802 $490 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $9.58 Million - $13.9 Million
37,355 Added 2.37%
1,614,224 $598 Million
Q1 2020

May 14, 2020

SELL
$209.2 - $335.53 $5.49 Million - $8.81 Million
-26,264 Reduced 1.64%
1,576,869 $431 Million
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $5.75 Million - $6.69 Million
-19,941 Reduced 1.23%
1,603,133 $532 Million
Q3 2019

Nov 13, 2019

SELL
$266.84 - $378.23 $15.9 Million - $22.5 Million
-59,469 Reduced 3.53%
1,623,074 $494 Million
Q2 2019

Aug 13, 2019

BUY
$300.59 - $368.15 $6.55 Million - $8.02 Million
21,782 Added 1.31%
1,682,543 $619 Million
Q1 2019

May 13, 2019

BUY
$272.57 - $321.18 $4 Million - $4.71 Million
14,669 Added 0.89%
1,660,761 $516 Million
Q4 2018

Feb 12, 2019

BUY
$272.46 - $366.54 $14.9 Million - $20 Million
54,642 Added 3.43%
1,646,092 $494 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $7.26 Million - $9.55 Million
-26,006 Reduced 1.61%
1,591,450 $584 Million
Q2 2018

Sep 18, 2018

SELL
$228.17 - $292.07 $2.19 Million - $2.81 Million
-9,616 Reduced 0.59%
1,617,456 $452 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $8.51 Million - $10.9 Million
37,305 Added 2.35%
1,627,072 $454 Million
Q1 2018

May 09, 2018

SELL
$209.54 - $253.91 $7.12 Million - $8.63 Million
-33,984 Reduced 2.09%
1,589,767 $376 Million
Q4 2017

Feb 14, 2018

SELL
$202.23 - $230.03 $7.75 Million - $8.81 Million
-38,319 Reduced 2.31%
1,623,751 $355 Million
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $286 Million - $356 Million
1,662,070
1,662,070 $331 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $16.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.